Verition Fund Management
MYOV

Verition Fund Management’s Myovant Sciences Ltd. MYOV Stock Holding History

Verition Fund Management’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-15,241
Closed -$347K – 2437
2021
Q2 		$347K Buy
+15,241
New +$321K ﹤0.01% 1276

Other funds holding MYOV

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Verition Fund Management's MYOV Position: Q3 2021 in Review

Verition Fund Management sold out of Myovant Sciences Ltd. (MYOV) in Q3 2021, closing a stake of 15,241 shares — an estimated $347K sold.

Verition Fund Management first reported a position in MYOV in Q2 2021 and held it in 1 quarter. The position peaked at $347K in Q2 2021. 105 funds tracked by Wall St. Rank hold MYOV as of Q3 2021.

  • Verition Fund Management reported no remaining Myovant Sciences Ltd. position as of Q3 2021 after selling out during the quarter.
  • Verition Fund Management sold 15,241 Myovant Sciences Ltd. shares in Q3 2021, an estimated $347K.
  • Verition Fund Management first reported a position in Myovant Sciences Ltd. in Q2 2021 and held it in 1 quarter.
  • Verition Fund Management's Myovant Sciences Ltd. position peaked at $347K in Q2 2021.
  • 105 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q3 2021.

Based on Verition Fund Management's 13F filing for Q3 2021, filed 15 Nov 2021.